Skip to main content
. 2022 Oct 12;22(1):3–11. doi: 10.1158/1535-7163.MCT-22-0243

Table 2.

Summary of gamma-secretase inhibitors (GSI) under clinical development in oncology.

GSI Company Clinical status Reference
BMS-906024 (AL101) Bristol Myers Squibb (BMS) 2 Chan et al (40)
BMS-986115 (AL102) Bristol Myers Squibb (BMS) 2 Aung et al (41)
LY-900009 Eli Lilly 1 Pant et al (42)
MK-0752 Merck 2 Cook et al (43)
PF-03084014 (Nirogacestat) Pfizer 3 Kummar et al (44), Takahashi et al (45)
RO4929097 (RG-4733) Roche 2 Lee et al (46), Sahebjam et al (47)